Indeed, Ki67 overexpression was proposed as a significant predictor of poor seizure control in GBM patients [72], while the activation of proinflammatory cytokines in response to inadequate homeostasis in the GBM tumor tissues was suggested as seizure susceptibility factors [73]. The gene discussed is MKI67; the disease is neoplasm.